首页>
外国专利>
Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor
Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor
展开▼
机译:顺铂和表皮生长因子受体激酶抑制剂的联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an EGFR kinase inhibitor and cisplatin combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and cisplatin combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCl (also known as Tarceva™).
展开▼